STADA: CapVest Completes Majority Acquisition Of Global Pharmaceuticals Company - Pulse 2.0
CapVest→STADA Arzneimittel
Apr 1, 2026
Millstreet Credit Fund has completed the acquisition of Cannabist Company, a substance abuse treatment business in Virginia, for $130 million. Cannabist Company operates cannabis cultivation, production, manufacturing, distribution, and retail services through active Virginia locations in the Richmond region, supporting healthcare M&A demand for regulated substance abuse treatment access. The Millstreet Credit Fund acquisitions focus on VA acquisitions tied to approximately 82,000 square feet of cultivation and production capacity, with one additional retail site in development. The divestiture acquisition closed as a private equity acquisition, with $117.5 million paid at closing and $12.5 million held in escrow subject to purchase price adjustment and indemnification, following partial redemption of Cannabist’s 2028 senior secured notes.
CapVest→STADA Arzneimittel
Apr 1, 2026
Lilly→Centessa Pharmaceuticals
Mar 31, 2026
Jimini Health
Mar 31, 2026
Eris Lifesciences→Velbiom Probiotics
Mar 31, 2026
Biogen→Apellis Pharmaceuticals
Mar 31, 2026